0001144204-17-007450.txt : 20170210
0001144204-17-007450.hdr.sgml : 20170210
20170210165210
ACCESSION NUMBER: 0001144204-17-007450
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20161231
FILED AS OF DATE: 20170210
DATE AS OF CHANGE: 20170210
EFFECTIVENESS DATE: 20170210
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management II, LLC
CENTRAL INDEX KEY: 0001594912
IRS NUMBER: 464028844
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16497
FILM NUMBER: 17594274
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001594912
XXXXXXXX
12-31-2016
12-31-2016
false
Foresite Capital Management II, LLC
600 Montgomery Street
Suite 4500
San Francisco
CA
94111
13F HOLDINGS REPORT
028-16497
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
02-10-2017
0
9
199266
INFORMATION TABLE
2
infotable.xml
Acceleron Pharma Inc.
COM
00434H108
508
19910
SH
SOLE
19910
0
0
Aerie Pharmaceuticals, Inc.
COM
00771V108
59604
1574749
SH
SOLE
1574749
0
0
Aimmune Therapeutics, Inc.
COM
00900T107
78443
3835830
SH
SOLE
3835830
0
0
Alder Biopharmaceuticals Inc.
COM
014339105
20704
995396
SH
SOLE
995396
0
0
Epizyme, Inc.
COM
29428V104
18472
1526637
SH
SOLE
1526637
0
0
NanoString Technologies, Inc.
COM
63009R109
15142
679033
SH
SOLE
679033
0
0
Nexvet Biopharma public limited company
ORD SHS
G6503X109
3338
894695
SH
SOLE
894695
0
0
Orexigen Therapeutics, Inc.
COM
686164302
944
542755
SH
SOLE
542755
0
0
Zafgen, Inc.
COM
98885E103
2111
663780
SH
SOLE
663780
0
0